Treasury Chief Rachel Reeves Intends Targeted Action on Living Costs in Upcoming Budget

Treasury head Reeves has announced she is preparing "specific action to address cost of living pressures" in next month's Budget.

During an interview with media outlets, she stated that lowering price rises is a shared duty of both the government and the central bank.

The United Kingdom's price growth is expected to be the highest among the Group of Seven advanced economies this year and the following year.

Possible Utility Cost Measures

Sources suggest the government could take action to lower utility costs, such as by cutting the present 5% level of value-added tax charged on energy.

Another approach is to lower some of the policy costs presently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the latest draft from the official forecaster, the OBR, on Monday, which will clarify how much space there is for these actions.

The view from the majority of economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to fulfill her declared debt limits.

Earlier on the same day, analysis suggested there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of expectations.

"It is a joint task between the central bank and the administration to continue tackling some of the drivers of inflation," Reeves stated to reporters in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the latest figures from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with rising international and trade issues for the fiscal tax moves, likely to be focused on those "most able to pay."

Global Trade Disputes

Commenting on apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests always come first."

Last week's announcement by Chinese authorities to increase export controls on critical minerals and other resources that are essential for high-technology production led American leader the US President to threaten an further 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary described the Chinese move "commercial pressure" and "a international production control attempt."

Inquired about considering the US offer to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "damaging for the global economy and creates further obstacles."

"It is my opinion there are areas where we need to confront China, but there are also valuable opportunities to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that balance right."

The Treasury chief also stated she was working with G7 counterparts "on our own essential resources plan, so that we are more independent."

NHS Medicine Pricing and Funding

Reeves also recognized that the price the National Health Service spends on drugs could go up as a consequence of current discussions with the US government and its drugs companies, in return for reduced taxes and funding.

A number of the biggest global drug companies have said recently that they are either delaying or canceling projects in the UK, with some attributing the insufficient payments they are getting.

Last month, the Science Minister said the cost the NHS spends on drugs would must increase to stop companies and pharmaceutical investment departing from the UK.

The Chancellor told the BBC: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been offered in the United Kingdom in the way that they are in other continental states."

"The objective is to ensure that patients receiving treatment from the NHS are can receive the top critical drugs in the world. And so we are reviewing all of that, and... seeking to secure more capital into Britain."